| Dr Brett Gamma, MD | |
|
9901 Medical Center Dr, Rockville, MD 20850-3357 | |
| (240) 364-2515 | |
| Not Available |
| Full Name | Dr Brett Gamma |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 31 Years |
| Location | 9901 Medical Center Dr, Rockville, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215980255 | NPI | - | NPPES |
| 225511100 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | D (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Healthcare Shady Grove Medical Center | Rockville, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adventist Physician Services Inc | 4284631540 | 123 |
News Archive
Alnylam Pharmaceuticals, Inc. and Genzyme, a Sanofi company, announced today that they have formed an exclusive alliance to develop and commercialize RNAi therapeutics targeting transthyretin (TTR) for the treatment of transthyretin-mediated amyloidosis (ATTR) in Japan and other Asia-Pacific countries.
Daily temperature fluctuations, not just high temperatures, play a significant role in the transmission of dengue, a deadly mosquito-borne disease that strikes millions of people in tropical and subtropical countries, according to ground-breaking research led by French, Thailand and U.S. scientists and conceived by medical entomologist Thomas Scott of the University of California, Davis.
Older patients with diabetes who are not dealing well with the disease are likely to have symptoms of depression, and spouses of older patients also suffer distress related to diabetes and its management, according to research from Purdue University.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
› Verified 8 days ago
| Entity Name | Mep Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164483558 PECOS PAC ID: 5193610319 Enrollment ID: O20040217000863 |
News Archive
Alnylam Pharmaceuticals, Inc. and Genzyme, a Sanofi company, announced today that they have formed an exclusive alliance to develop and commercialize RNAi therapeutics targeting transthyretin (TTR) for the treatment of transthyretin-mediated amyloidosis (ATTR) in Japan and other Asia-Pacific countries.
Daily temperature fluctuations, not just high temperatures, play a significant role in the transmission of dengue, a deadly mosquito-borne disease that strikes millions of people in tropical and subtropical countries, according to ground-breaking research led by French, Thailand and U.S. scientists and conceived by medical entomologist Thomas Scott of the University of California, Davis.
Older patients with diabetes who are not dealing well with the disease are likely to have symptoms of depression, and spouses of older patients also suffer distress related to diabetes and its management, according to research from Purdue University.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
› Verified 8 days ago
| Entity Name | Adventist Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376623207 PECOS PAC ID: 4284631540 Enrollment ID: O20061030000122 |
News Archive
Alnylam Pharmaceuticals, Inc. and Genzyme, a Sanofi company, announced today that they have formed an exclusive alliance to develop and commercialize RNAi therapeutics targeting transthyretin (TTR) for the treatment of transthyretin-mediated amyloidosis (ATTR) in Japan and other Asia-Pacific countries.
Daily temperature fluctuations, not just high temperatures, play a significant role in the transmission of dengue, a deadly mosquito-borne disease that strikes millions of people in tropical and subtropical countries, according to ground-breaking research led by French, Thailand and U.S. scientists and conceived by medical entomologist Thomas Scott of the University of California, Davis.
Older patients with diabetes who are not dealing well with the disease are likely to have symptoms of depression, and spouses of older patients also suffer distress related to diabetes and its management, according to research from Purdue University.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
› Verified 8 days ago
| Entity Name | Shady Grove Hyperbaric Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366489783 PECOS PAC ID: 3173681038 Enrollment ID: O20081021000547 |
News Archive
Alnylam Pharmaceuticals, Inc. and Genzyme, a Sanofi company, announced today that they have formed an exclusive alliance to develop and commercialize RNAi therapeutics targeting transthyretin (TTR) for the treatment of transthyretin-mediated amyloidosis (ATTR) in Japan and other Asia-Pacific countries.
Daily temperature fluctuations, not just high temperatures, play a significant role in the transmission of dengue, a deadly mosquito-borne disease that strikes millions of people in tropical and subtropical countries, according to ground-breaking research led by French, Thailand and U.S. scientists and conceived by medical entomologist Thomas Scott of the University of California, Davis.
Older patients with diabetes who are not dealing well with the disease are likely to have symptoms of depression, and spouses of older patients also suffer distress related to diabetes and its management, according to research from Purdue University.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
› Verified 8 days ago
| Entity Name | Usacs Integrated Acute Care Services Of Maryland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922598929 PECOS PAC ID: 4486900172 Enrollment ID: O20190604001354 |
News Archive
Alnylam Pharmaceuticals, Inc. and Genzyme, a Sanofi company, announced today that they have formed an exclusive alliance to develop and commercialize RNAi therapeutics targeting transthyretin (TTR) for the treatment of transthyretin-mediated amyloidosis (ATTR) in Japan and other Asia-Pacific countries.
Daily temperature fluctuations, not just high temperatures, play a significant role in the transmission of dengue, a deadly mosquito-borne disease that strikes millions of people in tropical and subtropical countries, according to ground-breaking research led by French, Thailand and U.S. scientists and conceived by medical entomologist Thomas Scott of the University of California, Davis.
Older patients with diabetes who are not dealing well with the disease are likely to have symptoms of depression, and spouses of older patients also suffer distress related to diabetes and its management, according to research from Purdue University.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brett Gamma, MD Po Box 17564, Baltimore, MD 21297-1564 Ph: (240) 364-2515 | Dr Brett Gamma, MD 9901 Medical Center Dr, Rockville, MD 20850-3357 Ph: (240) 364-2515 |
News Archive
Alnylam Pharmaceuticals, Inc. and Genzyme, a Sanofi company, announced today that they have formed an exclusive alliance to develop and commercialize RNAi therapeutics targeting transthyretin (TTR) for the treatment of transthyretin-mediated amyloidosis (ATTR) in Japan and other Asia-Pacific countries.
Daily temperature fluctuations, not just high temperatures, play a significant role in the transmission of dengue, a deadly mosquito-borne disease that strikes millions of people in tropical and subtropical countries, according to ground-breaking research led by French, Thailand and U.S. scientists and conceived by medical entomologist Thomas Scott of the University of California, Davis.
Older patients with diabetes who are not dealing well with the disease are likely to have symptoms of depression, and spouses of older patients also suffer distress related to diabetes and its management, according to research from Purdue University.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.
› Verified 8 days ago
Dr. Michael Anthony Sauri, M.D., M.P.H.&T.M. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15005 Shady Grove Road, Suite 450, Rockville, MD 20850 Phone: 301-738-6420 Fax: 301-738-2215 | |
Dr. Matthew William Kramp, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 726 Rockville Pike, Rockville, MD 20852 Phone: 240-546-3428 | |
Dr. Alexander Julian Wade, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9901 Medical Center Dr, Shady Grove Adventist Hospital, Rockville, MD 20850 Phone: 240-826-5739 | |
Dr. Nicole S Vetere, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 9901 Medical Center Drive, Shady Grove Adventist Hospital, Rockville, MD 20878 Phone: 240-826-7550 Fax: 240-364-9020 | |
Dr. Philip Jonathan Kaplan, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 15204 Omega Dr Ste 100, Rockville, MD 20850 Phone: 301-279-6750 Fax: 301-208-8953 | |
Jennifer L Eaton, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Health Resources And Services Administration, 5600 Fishers Lane, Rockville, MD 20857 Phone: 919-357-1891 |